Literature DB >> 12412016

Expression of oncostatin M in hematopoietic organs.

Shinobu Tamura1, Yoshihiro Morikawa, Atsushi Miyajima, Emiko Senba.   

Abstract

Murine oncostatin M (OSM), a member of the interleukin-6 (IL-6) -related cytokine subfamily, stimulates definitive hematopoiesis and liver development. The OSM gene was cloned as a cytokine-inducible early response gene in some hematopoietic cell lines. In this study, we performed in situ hybridization to examine the tissue distribution of cells expressing OSM mRNA in the developing and the adult mice. Its gene expression was seen in hematopoietic cells of developing liver from 11.5 days postcoitum (dpc), and persisted to the neonates. From 17.5 dpc, OSM mRNA-positive cells were found in other hematopoietic organs, including bone marrow, thymus, and spleen. The highest levels of gene expression were observed in the adult bone marrow. Most OSM-expressing cells expressed IL-5 receptor alpha subunit, a marker for eosinophil lineage. In addition, some positive cells expressed neutrophil elastase, which was used as a polymorphonuclear neutrophil (PMN) marker. After birth, OSM mRNA was expressed in tissue eosinophils in nonhematopoietic organs, including small intestine, lung, and skin. Our data revealed that eosinophil progenitors and eosinophils as well as PMNs are also an important cellular source of OSM in mice. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12412016     DOI: 10.1002/dvdy.10156

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  11 in total

1.  Oncostatin m maintains the hematopoietic microenvironment and retains hematopoietic progenitors in the bone marrow.

Authors:  Ken-ichi Minehata; Masaki Takeuchi; Yoko Hirabayashi; Tohru Inoue; Peter J Donovan; Minoru Tanaka; Atsushi Miyajima
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

2.  Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease.

Authors:  Kathryn L Pothoven; James E Norton; Kathryn E Hulse; Lydia A Suh; Roderick G Carter; Erin Rocci; Kathleen E Harris; Stephanie Shintani-Smith; David B Conley; Rakesh K Chandra; Mark C Liu; Atsushi Kato; Nirmala Gonsalves; Leslie C Grammer; Anju T Peters; Robert C Kern; Paul J Bryce; Bruce K Tan; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2015-04-01       Impact factor: 10.793

Review 3.  The barrier hypothesis and Oncostatin M: Restoration of epithelial barrier function as a novel therapeutic strategy for the treatment of type 2 inflammatory disease.

Authors:  Kathryn L Pothoven; Robert P Schleimer
Journal:  Tissue Barriers       Date:  2017-06-13

4.  Oncostatin M is a potential agent for the treatment of obesity and related metabolic disorders: a study in mice.

Authors:  Tadasuke Komori; Minoru Tanaka; Hiroto Furuta; Takashi Akamizu; Atsushi Miyajima; Yoshihiro Morikawa
Journal:  Diabetologia       Date:  2015-05-14       Impact factor: 10.122

5.  Oncostatin m is produced in adipose tissue and is regulated in conditions of obesity and type 2 diabetes.

Authors:  David Sanchez-Infantes; Ursula A White; Carrie M Elks; Ron F Morrison; Jeffrey M Gimble; Robert V Considine; Anthony W Ferrante; Eric Ravussin; Jacqueline M Stephens
Journal:  J Clin Endocrinol Metab       Date:  2013-12-02       Impact factor: 5.958

6.  Lack of oncostatin M receptor β leads to adipose tissue inflammation and insulin resistance by switching macrophage phenotype.

Authors:  Tadasuke Komori; Minoru Tanaka; Emiko Senba; Atsushi Miyajima; Yoshihiro Morikawa
Journal:  J Biol Chem       Date:  2013-06-11       Impact factor: 5.157

7.  Deficiency of oncostatin M receptor β (OSMRβ) exacerbates high-fat diet-induced obesity and related metabolic disorders in mice.

Authors:  Tadasuke Komori; Minoru Tanaka; Emiko Senba; Atsushi Miyajima; Yoshihiro Morikawa
Journal:  J Biol Chem       Date:  2014-04-02       Impact factor: 5.157

8.  The role of glycoprotein 130 family of cytokines in fetal rat lung development.

Authors:  Cristina Nogueira-Silva; Paulina Piairo; Emanuel Carvalho-Dias; Carla Veiga; Rute S Moura; Jorge Correia-Pinto
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

Review 9.  The enigmatic cytokine oncostatin m and roles in disease.

Authors:  Carl D Richards
Journal:  ISRN Inflamm       Date:  2013-12-08

10.  The Fox/Forkhead transcription factor family of the hemichordate Saccoglossus kowalevskii.

Authors:  Jens H Fritzenwanker; John Gerhart; Robert M Freeman; Christopher J Lowe
Journal:  Evodevo       Date:  2014-05-07       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.